Evidence map›Paper›PMID 25483080›Full record

ArticleCell cycle (Georgetown, Tex.)2014

The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest.

Shahrzad Shirazi Fard, Malin Thyselius, Charlotta All-Ericsson, Finn Hallböök

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Heterogeneity in retinoblastoma: a tale of molecules and models.Clinical and translational medicine · 2017
    Review
  7. A regulatory sequence from theMolecular vision · 2016
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. To go or not to go?Cell cycle (Georgetown, Tex.) · 2015
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shahrzad Shirazi Farda Department of Neuroscience ; BMC Uppsala University ; Uppsala , Sweden.
Malin Thyselius
Charlotta All-Ericsson
Finn Hallböök
Uppsala University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For proper development, cells need to coordinate proliferation and cell cycle-exit. This is mediated by a cascade of proteins making sure that each phase of the cell cycle is controlled before the initiation of the next. Retinal progenitor cells divide during the process of interkinetic nuclear migration, where they undergo S-phase on the basal side, followed by mitoses on the apical side of the neuroepithelium. The final cell cycle of chicken retinal horizontal cells (HCs) is an exception to this general cell cycle behavior. Lim1 expressing (+) horizontal progenitor cells (HPCs) have a heterogenic final cell cycle, with some cells undergoing a terminal mitosis on the basal side of the retina. The results in this study show that this terminal basal mitosis of Lim1+ HPCs is not dependent on Chk1/2 for its regulation compared to retinal cells undergoing interkinetic nuclear migration. Neither activating nor blocking Chk1 had an effect on the basal mitosis of Lim1+ HPCs. Furthermore, the Lim1+ HPCs were not sensitive to cisplatin-induced DNA damage and were able to continue into mitosis in the presence of γ-H2AX without activation of caspase-3. However, Nutlin3a-induced expression of p21 did reduce the mitoses, suggesting the presence of a functional p53/p21 response in HPCs. In contrast, the apical mitoses were blocked upon activation of either Chk1/2 or p21, indicating the importance of these proteins during the process of interkinetic nuclear migration. Inhibiting Cdk1 blocked M-phase transition both for apical and basal mitoses. This confirmed that the cyclin B1-Cdk1 complex was active and functional during the basal mitosis of Lim1+ HPCs. The regulation of the final cell cycle of Lim1+ HPCs is of particular interest since it has been shown that the HCs are able to sustain persistent DNA damage, remain in the cell cycle for an extended period of time and, consequently, survive for months.

Indexed as

AnimalsAntineoplastic AgentsCell Cycle CheckpointsChickensCisplatinLIM-Homeodomain ProteinsMitosisRetinal Horizontal CellsTranscription FactorsAntineoplastic AgentsCisplatinLHX1 protein, humanLIM-Homeodomain ProteinsTranscription FactorsATM, ataxia telangiectasia mutatedATM/ATRATR, ataxia telangiectasia Rad-3 related proteinC-casp-3, cleaved caspase 3Cdk1, cyclin-dependent kinase 1cell cycle regulationchk1Chk1, checkpoint kinase 1Chk2, checkpoint kinase 2cyclin B1-Cdk1E, Embryonic day;HCs, horizontal cellsHPCs, horizontal progenitor cellsINM, interkinetic nuclear migrationMdm2, murine double minute 2Mdm4/X, murine double minute 4/XNutlin3ap21p21, p21CIP1/waf1;p53PH3, PhosphoHistone 3retinast, stageTBP, TATA binding proteinγ-H2AX, phosphorylated histone H2AX

Identifiers

PMID25483080
PMCPMC4615048
OpenAlexW1983381862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.